{
  "title": "M21-1, Part V, Subpart iii, Chapter 1, Section E - Muscle Injuries",
  "url": "https://www.knowva.ebenefits.va.gov/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014422/M21-1-Part-V-Subpart-iii-Chapter-1-Section-E-Muscle-Injuries",
  "content": "<-- Previous Section\nNext Section -->\nOverview\nIn This Section\nThis section contains the following topics:\nTopic\nTopic Name\n1\nGeneral Principles for Evaluating Muscle Injuries\n2\nApplying 38 CFR 4.55, 4.56, and 4.73 for Muscle Injury Evaluations\n1\n.\nGeneral Principles for Evaluating Muscle Injuries\nIntroduction\nThis topic contains general principles for evaluating muscle injuries, including\ntypes of muscle injuries\nstandard muscle strength grading system for examinations\nidentification of muscle groups (MGs) in examination reports\n, and\nfractures associated with gunshot wound (GSW) and shell fragment wounds (SFW)\n.\nChange Date\nJuly 21, 2022\nV.iii.1.E.1.a\n.\nTypes of Muscle Injuries\nA missile that penetrates the body results in two problems\nit destroys muscle tissue in its direct path by crushing it, then\nthe temporary cavitation forces stretch the tissues adjacent to the missile track and result in additional injury or destruction.\nMuscles are much more severely disrupted if multiple penetrating projectiles strike in close proximity to each other.  Examples of this type of injury are\nexplosive device injuries\ndeforming or fragmenting rifle projectiles, or\nany rifle projectile that strikes bone.\nFor additional information regarding types of injuries, the effects of explosions and projectiles, and symptoms and complications, refer to the table below.\nType of Injury\nInitial Effects\nSigns, Symptoms, and Complications\nGunshots\nEntrance and exit wounds result. The amount of damage and relative size of entrance and exit wounds depends on many factors such as\ncaliber of bullet\ndistance from victim\norgans, bone, blood vessels, and other structures hit.\nExit wounds are generally larger than entrance wounds, and\nbullets are essentially sterile when they reach the body but carry particles into wound which could be sources of infection.\nFragments from explosive devices\nMost result in decreased tissue penetration compared to denser rifle bullets.\nMultiple fragments in a localized area result in tissue disruption affecting a wide area.\nTears and lacerations\nMuscles that become isolated from nerve supply by lacerations will be non-functional.\nTorn muscle fibers heal with very dense scar tissue, but the nerve stimulation will not cross this barrier.\nParts of muscle isolated from the nerve will most likely remain non-contractile resulting in a strength deficit proportional to amount of muscle tissue disrupted.\nTreatment for small tears is symptomatic.\nLarge tears/lacerations may require reconstruction.\nThrough and through wound\nInjuring instrument enters and exits one or multiple muscle groups.\nTwo wounds result\nentrance wound, and\nexit wound.\nReference\n:  For more information on the potential for multiple through and through wounds from a single injuring instrument, see\nJones v. Principi\n, 18 Vet.App. 248 (2004).\nReferences\n:  For more information on\nmuscle groups (MGs) and corresponding diagnostic codes (DCs), see\n38 CFR 4.73\nanatomical regions of the body, see\n38 CFR 4.55(b)\n, and\ngunshot wounds (GSWs) with pleural cavity involvement, see\n38 CFR 4.97, DC 6840-6845, Note (3)\n.\nV.iii.1.E.1.b\n.\nStandard Muscle Strength Grading System for Examinations\nRefer to the table below for information about how muscle strength is evaluated on an examination.\nNumeric Grade\nCorresponding Strength Assessment\nIndications on Exam\n(0)\nabsent\nno contraction felt\n(1)\ntrace\nmuscle can be felt to tighten but no movement is produced\n(2)\npoor\nmuscle movement is produced against gravity but cannot overcome resistance\n(3)\nfair\nmuscle movement is produced against gravity but cannot overcome resistance\n(4)\ngood\nmuscle movement is produced against resistance, however, less than normal resistance\n(5)\nnormal\nmuscle movement can overcome a normal resistance\nV.iii.1.E.1.c\n.\nIdentification of MG in Examination Reports\nThe examination report must include information to adequately identify the MG affected by either\nspecifically noting which MG is affected, or\nnoting which muscles are involved so that the name of the muscles may be used to identify the MG affected.\nV.iii.1.E.1.d\n.\nFractures Associated With GSW/SFW\nAll fractures associated with a GSW and/or shell fragment wound (SFW) will be considered open because all of them involve an opening to the outside.  Most GSW/SFW fractures are also comminuted due to the shattering nature of the injury.\n2\n.\nApplying 38 CFR 4.55, 4.56, and 4.73 for Muscle Injury Evaluations\nIntroduction\nThis topic contains information on applying 38 CFR 4.55, 4.56, and 4.73 for evaluations of muscle injuries, including\ngeneral criteria for muscle evaluations\ndetermining whether 38 CFR 4.55 applies to muscle injuries\napplying 38 CFR 4.55 to muscle injuries\nevaluating\njoint manifestations and muscle damage acting on the same joint\n, and\ndamage to multiple muscles within the same MG\nconsidering peripheral nerve involvement in muscle injuries\nevaluating\nmuscle injuries with peripheral nerve conditions of different etiology\nscars associated with muscle injuries\n, and\npainful motion associated with muscle injuries\napplying the amputation rule to muscle injuries\n, and\nevaluating muscle disabilities not involving shrapnel, GSWs, or other projectile-type injury\n.\nChange Date\nMay 16, 2022\nV.iii.1.E.2.a\n.\nGeneral Criteria for Muscle Evaluations\nEvaluation of muscle disabilities is the result of a multi-factorial consideration.  However, there are hallmark traits that are suggestive of certain corresponding evaluations.  Refer to the following table for additional information regarding these hallmark traits and the suggested corresponding disability evaluation.\nIf the evidence shows a history of ...\nThen consider evaluating the muscle injury as ...\nopen comminuted fracture\nwith\nmuscle damage, or\ntendon damage\nsevere.\nNote\n:  This level of impairment is specified by regulation at\n38 CFR 4.56(a)\n.\nthrough and through or deep penetrating wound by small high velocity missile or large low velocity missile\nwith\ndebridement\nprolonged infection, or\nsloughing of soft parts, and\nintermuscular scarring\nat least moderately severe.\nthrough and through injury\nwith muscle damage\nno less than moderate.\nNote\n:  This level of impairment is specified by regulation at\n38 CFR 4.56(b)\n.\nretained fragments in muscle tissue\nat least moderate.\ndeep penetrating wound\nwithout\nexplosive effect of high velocity missile\nresiduals of debridement, or\nprolonged infection\nat least moderate.\nImportant\n:  No single factor is controlling for the assignment of a disability evaluation for a muscle injury. The entire evidence picture must be taken into consideration.\nReference\n:  For more information on assigning disability evaluations for muscle injuries, see\nTropf v. Nicholson\n, 20 Vet.App. 317 (2006)\nRobertson v. Brown\n, 5 Vet.App. 70 (1993)\nJones v. Principi\n, 18 Vet.App. 248 (2004), and\n38 CFR 4.55\n.\nV.iii.1.E.2.b\n.\nDetermining Whether 38 CFR 4.55 Applies to Muscle Injuries\n38 CFR 4.55\napplies to certain combinations of muscle injuries and joint conditions.  Consider the provisions of\n38 CFR 4.55\nif\nthere are multiple MGs involved\nthe MG acts on a joint or joints, and/or\nthere is peripheral nerve damage to the same body part affected by the muscle.\nV.iii.1.E.2.c\n.\nApplying 38 CFR 4.55 to Muscle Injuries\nIf more than one MG is injured or affected or if the injured MG acts on a joint, conduct a preliminary review of the evidence to gather information needed to properly apply the provisions of\n38 CFR 4.55\n.  The information needed will include whether the\naffected MGs are in the same or different anatomic regions\nMGs are acting on a single joint or multiple joints, and\njoint or joints is/are ankylosed.\nAfter the preliminary review is complete, use the evidence gathered and apply the following table to determine how\n38 CFR 4.55\naffects the evaluation of the muscle injury.\nStep\nAction\n1\nDoes the MG(s) act on an ankylosed joint?\nIf\nyes\n, go to Step 2.\nIf\nno\n, go to Step 4.\n2\nFor MG(s) that act on an ankylosed joint, is the joint an ankylosed knee\nand\nis MG XIII disabled?\nIf\nyes\n, grant separate evaluations for the ankylosed knee and the MG XIII injury.  For the MG XIII injury, assign the next lower level than that which would otherwise be assigned.  Then go to Step 3.\nIf\nno\n, then is the ankylosed joint the shoulder\nand\nare MGs I and II\nseverely\ndisabled?\nIf\nyes\n, then assign a single evaluation for the muscle injury and the shoulder ankylosis under DC 5200.  The evaluation will be at the level of unfavorable ankylosis.\nIf\nno\n, then no evaluation will be assigned for the muscle injury.  The combined disability arising from the ankylosis and the muscle injury will be evaluated as ankylosis.\n3\nFor the injury to MG XIII with an associated ankylosed knee, are there other MG injuries in the same anatomical region affecting the pelvic girdle and/or thigh?\nIf\nno\n, then no additional change to the evaluation for the muscle injury is warranted.\nIf\nyes\n, do the affected MG injuries act on the ankylosed knee?\nIf\nyes\n, then no separate evaluation for the muscle injury to a MG other than MG XIII can be assigned, as indicated in Step 2.\nIf\nno\n, then for the MG XIII injury that acts on the knee and the injury to another MG of the pelvic girdle and thigh acting on a different joint, is the different joint ankylosed?\nIf\nyes\n, then no separate evaluation can be assigned for the other MG injury of the pelvic girdle and thigh, as indicated in Step 2.  No further action is warranted.\nIf\nno\n, then assign a single evaluation for the MG XIII injury and the injury to the other MG of the pelvic girdle and thigh anatomical region by determining the most severely injured MG and increasing by one level.\n4\nFor muscle injury(ies) acting on unankylosed joint(s), is a single MG injury involved?\nIf\nyes\n, then grant a single evaluation for the muscle injury.\nIf\nno\n, then are the MG injuries in the same anatomical region?\nIf\nyes\n, go to Step 5.\nIf\nno\n, go to Step 6.\n5\nDo the MGs in the same anatomical region act on a single joint?\nIf\nyes\n, are the MGs involved MG I and II acting on a shoulder joint?\nIf\nyes\n, then\nassign separate disability evaluations for the MGs, but\nthe combined evaluation cannot exceed the evaluation for unfavorable ankylosis of the shoulder.\nIf\nno\n, then for the muscles in the same anatomical region acting on a single joint,\nassign separate disability evaluations for the MGs, but\nthe combined evaluation must be less than the evaluation that would be normally assigned for unfavorable anklyosis of the joint involved.\nIf\nno\n, for the MGs in the same anatomical region acting on different joints, are the MG injuries compensable?\nIf\nyes\n, then assign a single disability evaluation for the affected MGs by\ndetermining the evaluation for the most severely injured MG, and\nincreasing by one level and using as the combined evaluation.\nIf\nno\n, then assign a noncompensable evaluation for the combined MG injuries.\n6\nFor MG injuries in different anatomical areas, is a single unankylosed joint affected?\nIf\nyes\n, are MG I and II affected and acting upon the shoulder?\nIf\nyes\n, then\nassign separate disability evaluations for the muscle injuries, but\nthe combined evaluation cannot exceed the evaluation for unfavorable ankylosis of the shoulder.\nIf\nno\n, for the MG injuries in different anatomical areas affecting a single unankylosed joint (not including MG I and II acting on the shoulder)\nassign separate disability evaluations for the muscle injuries, but\nthe combined evaluation must be lower than the evaluation that would be assigned for unfavorable ankylosis of the affected joint.\nIf\nno\n, then for MG injuries in different anatomical areas acting on different unankylosed joints, assign separate disability evaluations for each MG injury.\nReferences\n:  For additional information on evaluating\njoint manifestations and muscle damage acting on the same joint, see\nM21-1, Part V, Subpart iii, 1.E.2.d\n, and\nperipheral nerve involvement in muscle injuries, see\nM21-1 Part V, Subpart iii, 1.E.2.f\n.\nV.iii.1.E.2.d\n.\nEvaluating Joint Manifestations and Muscle Damage Acting on the Same Joint\nA separate evaluation for joint manifestations and muscle damage acting on the same joint are prohibited if both conditions result in the same symptoms.\nAlthough LOM is not directly discussed in\n38 CFR 4.56\n, the DC provisions within\n38 CFR 4.73\ndescribing the functions of various MGs are describing motion.\nThe muscles move the joint.\nIf the joint manifestation is LOM, that manifestation is already compensated through the evaluation assigned by a muscle rating decision.\nEvaluating the same symptoms under multiple DCs is prohibited by\n38 CFR 4.14\n.\nNote\n:  Consider the degree of disability under the corresponding muscle DC and joint DC and assign the higher evaluation.\nException\n:  Per\n38 CFR 4.55(c)(1)\n, if MG XIII is disabled and acts on an ankylosed knee, separate disability evaluations can be assigned for the muscle injury and the knee ankylosis.  However, the evaluation for the MG injury will be rated at the next lower level than that which would have otherwise been assigned.\nReference\n:  For more information on applying\n38 CFR 4.55\nwhen evaluating muscle injuries and joint conditions, see\nM21-1, Part V, Subpart iii, 1.E.2.b\nand\nc\n.\nV.iii.1.E.2.e\n.\nEvaluating Damage to Multiple Muscles Within the Same MG\nA separate evaluation cannot be assigned for each muscle within a single MG.  Muscle damage to any of the muscles within the group must be included in a single evaluation assigned for the MG.\nV.iii.1.E.2.f\n.\nConsidering Peripheral Nerve Involvement in Muscle Injuries\nWhen there is nerve damage associated with the muscle injury, use the table below to determine appropriate actions to take to evaluate the nerve damage and the muscle injury.\nIf ...\nThen ...\nthe nerve damage is in the same body part as the muscle injury,\nand\nthe muscle injury and the nerve damage affect the same functions of the affected body part\nassign a single evaluation for the combined impairment by determining whether the nerve code or the muscle code will result in a higher evaluation. Assign the higher evaluation.\nNote\n:  If the muscle and nerve evaluations are equal, evaluate with the DC with the highest maximum evaluation available.\nthe nerve damage is in the same body part as the muscle injury,\nand\nthe muscle injury and the nerve damage affect entirely different functions of the affected body part\nassign separate evaluations for the nerve damage and the muscle injury.\nV.iii.1.E.2.g\n.\nEvaluating Muscle Injuries with Peripheral Nerve Conditions of Different Etiology\nThe provisions of\n38 CFR 4.55\npreclude the combining of a muscle injury rating with a peripheral nerve paralysis evaluation involving the same body part when the same functions are affected.  A muscle injury and a peripheral nerve paralysis of the same body part, originating from separate etiologies, may not be rated separately.\nThe exception to this rule is only when entirely different functions are affected.\nEtiology of the disability is irrelevant in rendering a determination regarding combining evaluations for muscle injuries and peripheral nerve paralysis.\nExample\n:  A Veteran is service-connected (SC) for GSW to the right leg MG XI at 10-percent.  SC diabetic peripheral neuropathy develops many years later.  The peripheral neuropathy affects the external popliteal nerve.  Since MG XI and the external popliteal nerve both control the same functions, dorsiflexion of the foot and extension of the toes, only a single disability evaluation can be assigned under either\n38 CFR 4.73, DC 5311\nor\n38 CFR 4.73, DC 8521\n, whichever is more advantageous.\nV.iii.1.E.2.h\n.\nEvaluating Scars Associated With Muscle Injuries\nUse the table below to determine appropriate action to take when evaluating scars associated with muscle injuries.\nIf ...\nThen ...\nthere is scarring associated with the muscle injury\nassign a separate evaluation for the scar, even if noncompensable.\nthere is painful or unstable scarring associated with the muscle injury\nassign a separate compensable disability evaluation under\n38 CFR 4.118, DC 7804\n.\nthere is scarring that results in functional loss under\n38 CFR 4.118, DC 7805\nthat is compensable\ndo not assign a separate evaluation if the body part affected and the functional impairment resulting from the scar are the same as the part and function affected by the muscle injury.\nReference\n:  For more information on assigning separate evaluations for the muscle injury and associated scarring, see\nEsteban v. Brown\n, 6 Vet. App. 259 (1994)\nJones v. Principi\n, 18 Vet.App. 248 (2004), and\n38 CFR 4.14\n.\nV.iii.1.E.2.i\n.\nEvaluating Painful Motion Associated With Muscle Injuries\nFatigue-pain is a cardinal sign and symptom of muscle disability, as discussed in\n38 CFR 4.56(c)\n.  Painful motion associated with a muscle injury is consistent with fatigue-pain.  As noted in\n38 CFR 4.56(d)(2)(iii)\n, a record of consistent complaint of one or more of the cardinal signs and symptoms of muscle disability is consistent with at least moderate disability of the muscles.\nV.iii.1.E.2.j\n.\nApplying the Amputation Rule to Muscle Injuries\nThe amputation rule applies to musculoskeletal conditions and any associated peripheral nerve injuries.  Therefore, when assigning separate evaluations for the muscle injury, peripheral nerve injury directly related to that muscle injury must be considered in applying the amputation rule.\nReferences\n:  For more information on\nthe amputation rule, see\n38 CFR 4.68\n, and\nevaluating peripheral nerve disabilities associated with muscle injuries, see\nM21-1, Part V, Subpart iii, 1.E.2.f\n.\nV.iii.1.E.2.k\n.\nEvaluating Muscle Disabilities Not Involving Shrapnel, GSWs, or Other Projectile-Type Injury\nGenerally, apply\n38 CFR 4.73\nto muscle injuries such as those arising from shrapnel, GSWs, or other projectiles or similar foreign objects entering the muscle from outside the body since the criteria for the evaluation weigh heavily on the type of wound, treatment, and current manifestations of the wound.\nGenerally, a disability such as that arising from injuries such as muscle strains, tears not resulting from injury by a foreign object entering the muscle, or muscle atrophy due to a SC joint or nerve injury should be evaluated under an appropriate DC based on associated functional impairment.\nException\n:  Compartment syndrome is evaluated under\n38 CFR 4.73, DC 5331\nusing the muscle injury evaluation criteria.\n<-- Previous Section\nNext Section -->\nTo Top",
  "content_html": "<div class=\"article-content\">\n<div compile-custom=\"article.content\" ng-aria=\"articleContent\"><p class=\"ng-scope\"></p><div class=\"ng-scope\" style=\"text-align: right\"><span style=\"font-size: 11px\"><span style=\"font-family: arial , helvetica , sans-serif\"><a articleid=\"554400000014418\" articlename=\"M21-1, Part V, Subpart iii, Chapter 1, Section D - Osteomyelitis\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014418/M21-1-Part-V-Subpart-iii-Chapter-1-Section-D-Osteomyelitis\">&lt;-- Previous Section</a>  <a articleid=\"554400000014425\" articlename=\"M21-1, Part V, Subpart iii, Chapter 1, Section F - Other Musculoskeletal Considerations\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014425/M21-1-Part-V-Subpart-iii-Chapter-1-Section-F-Other-Musculoskeletal-Considerations\">Next Section --&gt;</a></span></span></div><h2 class=\"ng-scope\"><a id=\"top\" name=\"top\"><span style=\"font-size: 16px\"><span style=\"font-family: arial , helvetica , sans-serif\">Overview</span></span></a></h2><div class=\"ng-scope\" style=\"margin-left: 1.2in\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" class=\"ng-scope\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">In This Section</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"><p><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"> </span></span></p></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">This section contains the following topics: </span></span></div><div></div><table border=\"1\" cellpadding=\"1\" cellspacing=\"1\" style=\"border-spacing: 1px; border-collapse: revert;\" summary=\"Column 1 has the topic number and column 2 has the topic title.\" width=\"485\"><thead><tr><th scope=\"col\" style=\"width: 86px; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Topic</span></span></div></th><th scope=\"col\" style=\"width: 399px; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Topic Name</span></span></div></th></tr></thead><tbody><tr><td style=\"width: 86px; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">1</span></span></div></td><td style=\"width: 399px; padding: 1px;\"><div><a href=\"#1\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">General Principles for Evaluating Muscle Injuries</span></span></a></div></td></tr><tr><td style=\"width: 86px; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">2</span></span></div></td><td style=\"width: 399px; padding: 1px;\"><div><a href=\"#2\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Applying 38 CFR 4.55, 4.56, and 4.73 for Muscle Injury Evaluations</span></span></a></div></td></tr></tbody></table><div></div></td></tr></tbody></table><div class=\"ng-scope\" style=\"margin-left: 85pt\"><hr/><br/><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"> </span></span></div><div class=\"ng-scope\"><h2><span style=\"font-size: 16px\"><span style=\"font-family: arial , helvetica , sans-serif\">1<a id=\"1\" name=\"1\">.</a>  General Principles for Evaluating Muscle Injuries</span></span></h2><p><br/> </p><div style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Introduction</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">This topic contains general principles for evaluating muscle injuries, including</span></span></div><ul><li><div><a href=\"#1a\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">types of muscle injuries</span></span></a></div></li><li><div><a href=\"#1b\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">standard muscle strength grading system for examinations</span></span></a></div></li><li><div><a href=\"#1c\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">identification of muscle groups (MGs) in examination reports</span></span></a><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">, and</span></span></div></li><li><div><a href=\"#1d\" target=\"_self\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">fractures associated with gunshot wound (GSW) and shell fragment wounds (SFW)</span></span></a><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">.</span></span></div></li></ul></td></tr></tbody></table><div style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><strong><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Change Date</span></span></strong></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; vertical-align: top; padding: 0px;\"><p><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">July 21, 2022</span></span></p></td></tr></tbody></table><div style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.E.1.a<a id=\"1a\" name=\"1a\">.</a>  Types of Muscle Injuries</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; vertical-align: top; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">A missile that penetrates the body results in two problems</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">it destroys muscle tissue in its direct path by crushing it, then</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">the temporary cavitation forces stretch the tissues adjacent to the missile track and result in additional injury or destruction.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Muscles are much more severely disrupted if multiple penetrating projectiles strike in close proximity to each other.  Examples of this type of injury are</span></span></span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">explosive device injuries</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">deforming or fragmenting rifle projectiles, or</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">any rifle projectile that strikes bone.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">For additional information regarding types of injuries, the effects of explosions and projectiles, and symptoms and complications, refer to the table below.</span></span></div><div></div><table border=\"1\" cellpadding=\"1\" cellspacing=\"1\" style=\"width: 510px; border-spacing: 1px; border-collapse: revert;\" summary=\"Column 1 provides the type of injury, column 2 provides the initial effects, and column 3 provides the signs, symptoms, and complications.\" width=\"510\"><thead><tr><th scope=\"col\" style=\"width: 516px; vertical-align: top; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong>Type of Injury</strong></span></span></div></th><th scope=\"col\" style=\"width: 516px; vertical-align: top; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong>Initial Effects</strong></span></span></div></th><th scope=\"col\" style=\"width: 516px; vertical-align: top; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong>Signs, Symptoms, and Complications</strong></span></span></div></th></tr></thead><tbody><tr><td style=\"width: 516px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Gunshots</span></span></div></td><td style=\"width: 516px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Entrance and exit wounds result. The amount of damage and relative size of entrance and exit wounds depends on many factors such as</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">caliber of bullet</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">distance from victim</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">organs, bone, blood vessels, and other structures hit.</span></span></div></li></ul></td><td style=\"width: 516px; vertical-align: top; padding: 1px;\"><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Exit wounds are generally larger than entrance wounds, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">bullets are essentially sterile when they reach the body but carry particles into wound which could be sources of infection.</span></span></div></li></ul></td></tr><tr><td style=\"width: 516px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Fragments from explosive devices</span></span></div></td><td style=\"width: 516px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Most result in decreased tissue penetration compared to denser rifle bullets.</span></span></div></td><td style=\"width: 516px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Multiple fragments in a localized area result in tissue disruption affecting a wide area.</span></span></div></td></tr><tr><td style=\"width: 516px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Tears and lacerations</span></span></div></td><td style=\"width: 516px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Muscles that become isolated from nerve supply by lacerations will be non-functional.</span></span></div><div style=\"margin-left: 7.9pt\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"> </span></span></div></td><td style=\"width: 516px; vertical-align: top; padding: 1px;\"><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Torn muscle fibers heal with very dense scar tissue, but the nerve stimulation will not cross this barrier.</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Parts of muscle isolated from the nerve will most likely remain non-contractile resulting in a strength deficit proportional to amount of muscle tissue disrupted.</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Treatment for small tears is symptomatic.</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Large tears/lacerations may require reconstruction.</span></span></div></li></ul></td></tr><tr><td style=\"width: 516px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Through and through wound</span></span></div></td><td style=\"width: 516px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Injuring instrument enters and exits one or multiple muscle groups.</span></span></div></td><td style=\"width: 516px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Two wounds result</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">entrance wound, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">exit wound.</span></span></div></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><em><strong>Reference</strong></em>:  For more information on the potential for multiple through and through wounds from a single injuring instrument, see <a articleid=\"554400000015282\" articlename=\"Jones v. Principi, Aug 26, 2004, 18 Vet.App. 248\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000015282/Jones-v-Principi-Aug-26-2004-18-VetApp-248\"><em>Jones v. Principi</em></a>, 18 Vet.App. 248 (2004).</span></span></div></td></tr></tbody></table><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>References</em></strong>:  For more information on</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">muscle groups (MGs) and corresponding diagnostic codes (DCs), see <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=016559808328edc689352a04140359bf&amp;node=se38.1.4_173&amp;rgn=div8\" target=\"_blank\">38 CFR 4.73</a></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">anatomical regions of the body, see <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=016559808328edc689352a04140359bf&amp;node=se38.1.4_155&amp;rgn=div8\" target=\"_blank\">38 CFR 4.55(b)</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">gunshot wounds (GSWs) with pleural cavity involvement, see <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=fac28fd48626614c9d2369ea61c7d14a&amp;node=se38.1.4_197&amp;rgn=div8\" target=\"_blank\">38 CFR 4.97, DC 6840-6845, Note (3)</a>.</span></span></div></li></ul></td></tr></tbody></table><div style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.E.1.b<a id=\"1b\" name=\"1b\">.</a>  Standard Muscle Strength Grading System for Examinations</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Refer to the table below for information about how muscle strength is evaluated on an examination.</span></span></div><div></div><div><table border=\"1\" cellpadding=\"1\" cellspacing=\"1\" style=\"width: 510px; border-spacing: 1px; border-collapse: revert;\" summary=\"Column 1 provides the numeric grade, column 2 provides the corresponding strength assessment, and column 3 provides information about how muscle strength is evaluated on an examination.\" width=\"510\"><thead><tr><th scope=\"col\" style=\"width: 90px; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong>Numeric Grade</strong></span></span></div></th><th scope=\"col\" style=\"width: 192px; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong>Corresponding Strength Assessment</strong></span></span></div></th><th scope=\"col\" style=\"width: 228px; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong>Indications on Exam</strong></span></span></div></th></tr></thead><tbody><tr><td style=\"width: 90px; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">(0)</span></span></div></td><td style=\"width: 192px; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">absent</span></span></div></td><td style=\"width: 228px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">no contraction felt</span></span></div></td></tr><tr><td style=\"width: 90px; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">(1)</span></span></div></td><td style=\"width: 192px; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">trace</span></span></div></td><td style=\"width: 228px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">muscle can be felt to tighten but no movement is produced</span></span></div></td></tr><tr><td style=\"width: 90px; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">(2)</span></span></div></td><td style=\"width: 192px; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">poor</span></span></div></td><td style=\"width: 228px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">muscle movement is produced against gravity but cannot overcome resistance</span></span></div></td></tr><tr><td style=\"width: 90px; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">(3)</span></span></div></td><td style=\"width: 192px; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">fair</span></span></div></td><td style=\"width: 228px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">muscle movement is produced against gravity but cannot overcome resistance</span></span></div></td></tr><tr><td style=\"width: 90px; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">(4)</span></span></div></td><td style=\"width: 192px; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">good</span></span></div></td><td style=\"width: 228px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">muscle movement is produced against resistance, however, less than normal resistance</span></span></div></td></tr><tr><td style=\"width: 90px; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">(5)</span></span></div></td><td style=\"width: 192px; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">normal</span></span></div></td><td style=\"width: 228px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">muscle movement can overcome a normal resistance</span></span></div></td></tr></tbody></table></div><div></div></td></tr></tbody></table><div style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.E.1.c<a id=\"1c\" name=\"1c\">.</a>  Identification of MG in Examination Reports</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; vertical-align: top; padding: 0px;\"><p><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">The examination report must include information to adequately identify the MG affected by either</span></span></p><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">specifically noting which MG is affected, or</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">noting which muscles are involved so that the name of the muscles may be used to identify the MG affected.</span></span></li></ul></td></tr></tbody></table><div style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.E.1.d<a id=\"1d\" name=\"1d\">.</a>  Fractures Associated With GSW/SFW</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; vertical-align: top; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">All fractures associated with a GSW and/or shell fragment wound (SFW) will be considered open because all of them involve an opening to the outside.  Most GSW/SFW fractures are also comminuted due to the shattering nature of the injury.</span></span></div></td></tr></tbody></table><div style=\"margin-left: 85pt\"><hr/></div><p></p><p></p><h2><strong><span style=\"font-size: 16px\"><span style=\"font-family: arial , helvetica , sans-serif\">2<a id=\"2\" name=\"2\">.</a>   Applying 38 CFR 4.55, 4.56, and 4.73 for Muscle Injury Evaluations</span></span></strong></h2><p><br/> </p><div style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Introduction</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">This topic contains information on applying 38 CFR 4.55, 4.56, and 4.73 for evaluations of muscle injuries, including</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2a\" target=\"_self\">general criteria for muscle evaluations</a></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2b\" target=\"_self\">determining whether 38 CFR 4.55 applies to muscle injuries</a></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2c\" target=\"_self\">applying 38 CFR 4.55 to muscle injuries</a></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">evaluating </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2d\" target=\"_self\">joint manifestations and muscle damage acting on the same joint</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2e\" target=\"_self\">damage to multiple muscles within the same MG</a></span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2f\" target=\"_self\">considering peripheral nerve involvement in muscle injuries</a></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">evaluating </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2g\" target=\"_self\">muscle injuries with peripheral nerve conditions of different etiology</a></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2h\" target=\"_self\">scars associated with muscle injuries</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2i\" target=\"_self\">painful motion associated with muscle injuries</a></span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2j\" target=\"_self\">applying the amputation rule to muscle injuries</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"#2k\" target=\"_self\">evaluating muscle disabilities not involving shrapnel, GSWs, or other projectile-type injury</a>.</span></span></div></li></ul></td></tr></tbody></table><div style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><strong><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Change Date</span></span></strong></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; vertical-align: top; padding: 0px;\"><p><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">May 16, 2022</span></span></p></td></tr></tbody></table><div style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.E.2.a<a id=\"2a\" name=\"2a\">.</a>  General Criteria for Muscle Evaluations</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; vertical-align: top; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Evaluation of muscle disabilities is the result of a multi-factorial consideration.  However, there are hallmark traits that are suggestive of certain corresponding evaluations.  Refer to the following table for additional information regarding these hallmark traits and the suggested corresponding disability evaluation.</span></span></div><div></div><table border=\"1\" cellpadding=\"1\" cellspacing=\"1\" style=\"width: 510px; border-spacing: 1px; border-collapse: revert;\" summary=\"This is an If-Then table.  Column 1 provides the criteria and column 2 provides additional information regarding these hallmark traits and the suggested corresponding disability evaluation\" width=\"510\"><thead><tr><th scope=\"col\" style=\"width: 516px; vertical-align: top; padding: 1px;\"><div style=\"text-align: left\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong>If the evidence shows a history of ...</strong></span></span></div></th><th scope=\"col\" style=\"width: 516px; vertical-align: top; padding: 1px;\"><div style=\"text-align: left\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong>Then consider evaluating the muscle injury as ...</strong></span></span></div></th></tr></thead><tbody><tr><td style=\"width: 516px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">open comminuted fracture <em>with</em></span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">muscle damage, or</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">tendon damage</span></span></div></li></ul></td><td style=\"width: 516px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">severe.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Note</em></strong>:  This level of impairment is specified by regulation at <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=58c48f445b6cd16d9747462b22ebb5f6&amp;node=se38.1.4_156&amp;rgn=div8\" target=\"_blank\">38 CFR 4.56(a)</a>.</span></span></div></td></tr><tr><td style=\"width: 516px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">through and through or deep penetrating wound by small high velocity missile or large low velocity missile <em>with</em></span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">debridement</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">prolonged infection, or</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">sloughing of soft parts, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">intermuscular scarring</span></span></div></li></ul></td><td style=\"width: 516px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">at least moderately severe.</span></span></div></td></tr><tr><td style=\"width: 516px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">through and through injury <em>with muscle damage</em></span></span></div></td><td style=\"width: 516px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">no less than moderate.</span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Note</em></strong>:  This level of impairment is specified by regulation at <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=58c48f445b6cd16d9747462b22ebb5f6&amp;node=se38.1.4_156&amp;rgn=div8\" target=\"_blank\">38 CFR 4.56(b)</a>.</span></span></div></td></tr><tr><td style=\"width: 516px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">retained fragments in muscle tissue</span></span></div></td><td style=\"width: 516px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">at least moderate.</span></span></div></td></tr><tr><td style=\"width: 516px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">deep penetrating wound <em>without</em></span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">explosive effect of high velocity missile</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">residuals of debridement, or</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">prolonged infection</span></span></div></li></ul></td><td style=\"width: 516px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">at least moderate.</span></span></div></td></tr></tbody></table><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Important</em></strong>:  No single factor is controlling for the assignment of a disability evaluation for a muscle injury. The entire evidence picture must be taken into consideration.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">  </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong><em>Reference</em></strong>:  For more information on assigning disability evaluations for muscle injuries, see</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000014887\" articlename=\"Tropf v. Nicholson, Aug 24, 2006, 20 Vet.App. 317\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014887/Tropf-v-Nicholson-Aug-24-2006-20-VetApp-317\"><em>Tropf v. Nicholson</em></a>, 20 Vet.App. 317 (2006)</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000083039\" articlename=\"Robertson v. Brown, Apr 28, 1993, 5 Vet.App. 70 (1993)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000083039/Robertson-v-Brown-Apr-28-1993-5-VetApp-70-1993\"><em>Robertson v. Brown</em></a>, 5 Vet.App. 70 (1993)</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a articleid=\"554400000015282\" articlename=\"Jones v. Principi, Aug 26, 2004, 18 Vet.App. 248\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000015282/Jones-v-Principi-Aug-26-2004-18-VetApp-248\"><em>Jones v. Principi</em></a>, 18 Vet.App. 248 (2004), and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=9c0c584b7efb6e6d288e4bc92f6c1cca&amp;mc=true&amp;node=se38.1.4_155&amp;rgn=div8\" target=\"_blank\">38 CFR 4.55</a>.</span></span></div></li></ul></td></tr></tbody></table><div style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.E.2.b<a id=\"2b\" name=\"2b\">.</a>  Determining Whether 38 CFR 4.55 Applies to Muscle Injuries</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><p><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=dfe9837fdb70e234eb6088450d0c7320&amp;node=se38.1.4_155&amp;rgn=div8\" target=\"_blank\">38 CFR 4.55</a> applies to certain combinations of muscle injuries and joint conditions.  Consider the provisions of <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=dfe9837fdb70e234eb6088450d0c7320&amp;node=se38.1.4_155&amp;rgn=div8\" target=\"_blank\">38 CFR 4.55</a> if</span></span></p><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">there are multiple MGs involved</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">the MG acts on a joint or joints, and/or</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">there is peripheral nerve damage to the same body part affected by the muscle.</span></span></li></ul></td></tr></tbody></table><div style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.E.2.c<a id=\"2c\" name=\"2c\">.</a>  Applying 38 CFR 4.55 to Muscle Injuries</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; vertical-align: top; padding: 0px;\"><p><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">If more than one MG is injured or affected or if the injured MG acts on a joint, conduct a preliminary review of the evidence to gather information needed to properly apply the provisions of <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=dfe9837fdb70e234eb6088450d0c7320&amp;node=se38.1.4_155&amp;rgn=div8\" target=\"_blank\">38 CFR 4.55</a>.  The information needed will include whether the</span></span></p><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">affected MGs are in the same or different anatomic regions</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">MGs are acting on a single joint or multiple joints, and</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">joint or joints is/are ankylosed.</span></span></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">After the preliminary review is complete, use the evidence gathered and apply the following table to determine how <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=dfe9837fdb70e234eb6088450d0c7320&amp;node=se38.1.4_155&amp;rgn=div8\" target=\"_blank\">38 CFR 4.55</a> affects the evaluation of the muscle injury.</span></span></div><div></div><div><table border=\"1\" cellpadding=\"1\" cellspacing=\"1\" style=\"width: 510px; border-spacing: 1px; border-collapse: revert;\" summary=\"This is a step-action table.  Column 1 is the step number and column 2 provides actions to take to use the evidence gathered to determine how 38 CFR 4.55 affects the evaluation of the muscle injury.\" width=\"510\"><thead><tr><th scope=\"col\" style=\"width: 66px; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>Step</strong></span></span></div></th><th scope=\"col\" style=\"width: 444px; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"><strong>Action</strong></span></span></div></th></tr></thead><tbody><tr><td style=\"width: 66px; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">1</span></span></div></td><td style=\"width: 444px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Does the MG(s) act on an ankylosed joint?<span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">If <em>yes</em>, go to Step 2.</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">If <em>no</em>, go to Step 4.</span></span></div></li></ul></td></tr><tr><td style=\"width: 66px; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">2</span></span></div></td><td style=\"width: 444px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">For MG(s) that act on an ankylosed joint, is the joint an ankylosed knee <em>and</em> is MG XIII disabled? <span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">If <em>yes</em>, grant separate evaluations for the ankylosed knee and the MG XIII injury.  For the MG XIII injury, assign the next lower level than that which would otherwise be assigned.  Then go to Step 3.</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">If <em>no</em>, then is the ankylosed joint the shoulder <em>and</em> are MGs I and II <em>severely</em> disabled? </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">If <em>yes</em>, then assign a single evaluation for the muscle injury and the shoulder ankylosis under DC 5200.  The evaluation will be at the level of unfavorable ankylosis.</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">If <em>no</em>, then no evaluation will be assigned for the muscle injury.  The combined disability arising from the ankylosis and the muscle injury will be evaluated as ankylosis.</span></span></div></li></ul></li></ul></td></tr><tr><td style=\"width: 66px; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">3</span></span></div></td><td style=\"width: 444px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">For the injury to MG XIII with an associated ankylosed knee, are there other MG injuries in the same anatomical region affecting the pelvic girdle and/or thigh?<span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">If <em>no</em>, then no additional change to the evaluation for the muscle injury is warranted.</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">If <em>yes</em>, do the affected MG injuries act on the ankylosed knee?</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">If <em>yes</em>, then no separate evaluation for the muscle injury to a MG other than MG XIII can be assigned, as indicated in Step 2.</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">If <em>no</em>, then for the MG XIII injury that acts on the knee and the injury to another MG of the pelvic girdle and thigh acting on a different joint, is the different joint ankylosed?</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">If <em>yes</em>, then no separate evaluation can be assigned for the other MG injury of the pelvic girdle and thigh, as indicated in Step 2.  No further action is warranted.</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">If <em>no</em>, then assign a single evaluation for the MG XIII injury and the injury to the other MG of the pelvic girdle and thigh anatomical region by determining the most severely injured MG and increasing by one level.</span></span></div></li></ul></li></ul></li></ul></td></tr><tr><td style=\"width: 66px; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">4</span></span></div></td><td style=\"width: 444px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">For muscle injury(ies) acting on unankylosed joint(s), is a single MG injury involved?<span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">If <em>yes</em>, then grant a single evaluation for the muscle injury.</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">If <em>no</em>, then are the MG injuries in the same anatomical region?</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">If <em>yes</em>, go to Step 5.</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">If <em>no</em>, go to Step 6.</span></span></div></li></ul></li></ul></td></tr><tr><td style=\"width: 66px; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">5</span></span></div></td><td style=\"width: 444px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Do the MGs in the same anatomical region act on a single joint?<span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">If <em>yes</em>, are the MGs involved MG I and II acting on a shoulder joint?</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">If <em>yes</em>, then</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">assign separate disability evaluations for the MGs, but</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">the combined evaluation cannot exceed the evaluation for unfavorable ankylosis of the shoulder.</span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">If <em>no</em>, then for the muscles in the same anatomical region acting on a single joint,</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">assign separate disability evaluations for the MGs, but</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">the combined evaluation must be less than the evaluation that would be normally assigned for unfavorable anklyosis of the joint involved. </span></span></div></li></ul></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">If <em>no</em>, for the MGs in the same anatomical region acting on different joints, are the MG injuries compensable? </span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">If <em>yes</em>, then assign a single disability evaluation for the affected MGs by</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">determining the evaluation for the most severely injured MG, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">increasing by one level and using as the combined evaluation.</span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">If <em>no</em>, then assign a noncompensable evaluation for the combined MG injuries.</span></span></div></li></ul></li></ul></td></tr><tr><td style=\"width: 66px; padding: 1px;\"><div align=\"center\"><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">6</span></span></div></td><td style=\"width: 444px; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">For MG injuries in different anatomical areas, is a single unankylosed joint affected?<span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">If <em>yes</em>, are MG I and II affected and acting upon the shoulder?</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">If <em>yes</em>, then</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">assign separate disability evaluations for the muscle injuries, but</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">the combined evaluation cannot exceed the evaluation for unfavorable ankylosis of the shoulder.</span></span></div></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">If <em>no</em>, for the MG injuries in different anatomical areas affecting a single unankylosed joint (not including MG I and II acting on the shoulder)</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">assign separate disability evaluations for the muscle injuries, but</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">the combined evaluation must be lower than the evaluation that would be assigned for unfavorable ankylosis of the affected joint. </span></span></div></li></ul></li></ul></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">If <em>no</em>, then for MG injuries in different anatomical areas acting on different unankylosed joints, assign separate disability evaluations for each MG injury.</span></span></div></li></ul></td></tr></tbody></table></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>References</em></strong>:  For additional information on evaluating</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">joint manifestations and muscle damage acting on the same joint, see <a href=\"#2d\" target=\"_self\">M21-1, Part V, Subpart iii, 1.E.2.d</a>, and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">peripheral nerve involvement in muscle injuries, see <a href=\"#2f\" target=\"_self\">M21-1 Part V, Subpart iii, 1.E.2.f</a>.</span></span></div></li></ul></td></tr></tbody></table><div style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.E.2.d<a id=\"2d\" name=\"2d\">.</a>  Evaluating Joint Manifestations and Muscle Damage Acting on the Same Joint</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">A separate evaluation for joint manifestations and muscle damage acting on the same joint are prohibited if both conditions result in the same symptoms.</span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Although LOM is not directly discussed in <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=cbcf4a87e1bca06ca12cebf47eece30e&amp;node=se38.1.4_156&amp;rgn=div8http://www.ecfr.gov/cgi-bin/text-idx?SID=cbcf4a87e1bca06ca12cebf47eece30e&amp;node=se38.1.4_156&amp;rgn=div8\" target=\"_blank\">38 CFR 4.56</a>, the DC provisions within <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=cbcf4a87e1bca06ca12cebf47eece30e&amp;node=se38.1.4_173&amp;rgn=div8\" target=\"_blank\">38 CFR 4.73</a> describing the functions of various MGs are describing motion. </span></span></div><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">The muscles move the joint. </span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">If the joint manifestation is LOM, that manifestation is already compensated through the evaluation assigned by a muscle rating decision. </span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Evaluating the same symptoms under multiple DCs is prohibited by <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=70df8a154d2bdffaab9f94956057a637&amp;node=se38.1.4_114&amp;rgn=div8\" target=\"_blank\">38 CFR 4.14</a>.</span></span></li></ul><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Note</em></strong>:  Consider the degree of disability under the corresponding muscle DC and joint DC and assign the higher evaluation.</span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Exception</em></strong>:  Per <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=cbc3aa622e44ec12918333696ffb3bff&amp;node=se38.1.4_155&amp;rgn=div8\" target=\"_blank\">38 CFR 4.55(c)(1)</a>, if MG XIII is disabled and acts on an ankylosed knee, separate disability evaluations can be assigned for the muscle injury and the knee ankylosis.  However, the evaluation for the MG injury will be rated at the next lower level than that which would have otherwise been assigned. </span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Reference</em></strong>:  For more information on applying <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=cbc3aa622e44ec12918333696ffb3bff&amp;node=se38.1.4_155&amp;rgn=div8\" target=\"_blank\">38 CFR 4.55</a> when evaluating muscle injuries and joint conditions, see <a href=\"#2b\" target=\"_self\">M21-1, Part V, Subpart iii, 1.E.2.b</a> and <a href=\"#2c\" target=\"_self\">c</a>.  </span></span></div></td></tr></tbody></table><div style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.E.2.e<a id=\"2e\" name=\"2e\">.</a>  Evaluating Damage to Multiple Muscles Within the Same MG</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; vertical-align: top; padding: 0px;\"><p><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">A separate evaluation cannot be assigned for each muscle within a single MG.  Muscle damage to any of the muscles within the group must be included in a single evaluation assigned for the MG. </span></span></p></td></tr></tbody></table><div style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.E.2.f<a id=\"2f\" name=\"2f\">.</a>  Considering Peripheral Nerve Involvement in Muscle Injuries</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; vertical-align: top; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">When there is nerve damage associated with the muscle injury, use the table below to determine appropriate actions to take to evaluate the nerve damage and the muscle injury.</span></span></div><div></div><div><table border=\"1\" cellpadding=\"1\" cellspacing=\"1\" style=\"width: 510px; border-spacing: 1px; border-collapse: revert;\" summary=\"This is an If-Then table.  Column 1 provides the criteria and column 2 provides information to determine appropriate actions to take to evaluate the nerve damage and the muscle injury.\" width=\"510\"><thead><tr><th scope=\"col\" style=\"width: 516px; vertical-align: top; padding: 1px;\"><div style=\"text-align: left\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong>If ...</strong></span></span></div></th><th scope=\"col\" style=\"width: 516px; vertical-align: top; padding: 1px;\"><div style=\"text-align: left\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong>Then ...</strong></span></span></div></th></tr></thead><tbody><tr><td style=\"width: 516px; vertical-align: top; padding: 1px;\"><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">the nerve damage is in the same body part as the muscle injury, <em>and</em></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">the muscle injury and the nerve damage affect the same functions of the affected body part</span></span></div></li></ul></td><td style=\"width: 516px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">assign a single evaluation for the combined impairment by determining whether the nerve code or the muscle code will result in a higher evaluation. Assign the higher evaluation.</span></span></div><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Note</em></strong>:  If the muscle and nerve evaluations are equal, evaluate with the DC with the highest maximum evaluation available.</span></span></div></td></tr><tr><td style=\"width: 516px; vertical-align: top; padding: 1px;\"><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">the nerve damage is in the same body part as the muscle injury, <em>and</em></span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">the muscle injury and the nerve damage affect entirely different functions of the affected body part</span></span></div></li></ul></td><td style=\"width: 516px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">assign separate evaluations for the nerve damage and the muscle injury.</span></span></div></td></tr></tbody></table></div><div></div></td></tr></tbody></table><div style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.E.2.g<a id=\"2g\" name=\"2g\">.</a>  Evaluating Muscle Injuries with Peripheral Nerve Conditions of Different Etiology</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><p><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">The provisions of <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=dfe9837fdb70e234eb6088450d0c7320&amp;node=se38.1.4_155&amp;rgn=div8\" target=\"_blank\">38 CFR 4.55</a> preclude the combining of a muscle injury rating with a peripheral nerve paralysis evaluation involving the same body part when the same functions are affected.  A muscle injury and a peripheral nerve paralysis of the same body part, originating from separate etiologies, may not be rated separately. </span></span></p><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">The exception to this rule is only when entirely different functions are affected.</span></span></li><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Etiology of the disability is irrelevant in rendering a determination regarding combining evaluations for muscle injuries and peripheral nerve paralysis. </span></span></li></ul><p><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Example</em></strong>:  A Veteran is service-connected (SC) for GSW to the right leg MG XI at 10-percent.  SC diabetic peripheral neuropathy develops many years later.  The peripheral neuropathy affects the external popliteal nerve.  Since MG XI and the external popliteal nerve both control the same functions, dorsiflexion of the foot and extension of the toes, only a single disability evaluation can be assigned under either <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=174c60495ce1e9c0d4884c37335612a8&amp;node=se38.1.4_173&amp;rgn=div8\" target=\"_blank\">38 CFR 4.73, DC 5311</a> or <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=174c60495ce1e9c0d4884c37335612a8&amp;node=se38.1.4_173&amp;rgn=div8\" target=\"_blank\">38 CFR 4.73, DC 8521</a>, whichever is more advantageous.</span></span></p></td></tr></tbody></table><div style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">V.iii.1.E.2.h<a id=\"2h\" name=\"2h\">.</a>  Evaluating Scars Associated With Muscle Injuries</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; vertical-align: top; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">Use the table below to determine appropriate action to take when evaluating scars associated with muscle injuries.</span></span></div><div></div><table border=\"1\" cellpadding=\"1\" cellspacing=\"1\" style=\"width: 510px; border-spacing: 1px; border-collapse: revert;\" summary=\"This is an If-Then table.  Column 1 provides the criteria and column 2 provides information to determine appropriate action to take when evaluating scars associated with muscle injuries.\" width=\"510\"><thead><tr><th scope=\"col\" style=\"width: 516px; vertical-align: top; padding: 1px;\"><div style=\"text-align: left\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong>If ...</strong></span></span></div></th><th scope=\"col\" style=\"width: 516px; vertical-align: top; padding: 1px;\"><div style=\"text-align: left\"><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong>Then ...</strong></span></span></div></th></tr></thead><tbody><tr><td style=\"width: 516px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">there is scarring associated with the muscle injury</span></span></div></td><td style=\"width: 516px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">assign a separate evaluation for the scar, even if noncompensable.</span></span></div></td></tr><tr><td style=\"width: 516px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">there is painful or unstable scarring associated with the muscle injury</span></span></div></td><td style=\"width: 516px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">assign a separate compensable disability evaluation under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=8fa6724d3188ec09c13ff6af41f7cf4c&amp;node=se38.1.4_1118&amp;rgn=div8\" target=\"_blank\">38 CFR 4.118, DC 7804</a>.</span></span></div></td></tr><tr><td style=\"width: 516px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">there is scarring that results in functional loss under <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=8fa6724d3188ec09c13ff6af41f7cf4c&amp;node=se38.1.4_1118&amp;rgn=div8\" target=\"_blank\">38 CFR 4.118, DC 7805</a> that is compensable</span></span></div></td><td style=\"width: 516px; vertical-align: top; padding: 1px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">do not assign a separate evaluation if the body part affected and the functional impairment resulting from the scar are the same as the part and function affected by the muscle injury.</span></span></div></td></tr></tbody></table><div></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>Reference</em></strong>:  For more information on assigning separate evaluations for the muscle injury and associated scarring, see</span></span></div><ul><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><a articleid=\"554400000066775\" articlename=\"Esteban v. Brown, February 25, 1994, 6 Vet.App. 259 (1994)\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000066775/Esteban-v-Brown-February-25-1994-6-VetApp-259-1994\"><em>Esteban v. Brown</em></a>, 6 Vet. App. 259 (1994)</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><a articleid=\"554400000015282\" articlename=\"Jones v. Principi, Aug 26, 2004, 18 Vet.App. 248\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000015282/Jones-v-Principi-Aug-26-2004-18-VetApp-248\"><em>Jones v. Principi</em></a>, 18 Vet.App. 248 (2004), and</span></span></div></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=79ee3fbf439e8c4e6ee385ec809fbab9&amp;node=se38.1.4_114&amp;rgn=div8\" target=\"_blank\">38 CFR 4.14</a>.</span></span></div></li></ul></td></tr></tbody></table><div style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.iii.1.E.2.i<a id=\"2i\" name=\"2i\">.</a>  Evaluating Painful Motion Associated With Muscle Injuries </span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; vertical-align: top; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Fatigue-pain is a cardinal sign and symptom of muscle disability, as discussed in <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=8837da85076ce3ed1d7519c6c769a3bc&amp;mc=true&amp;node=se38.1.4_156&amp;rgn=div8\" target=\"_blank\">38 CFR 4.56(c)</a>.  Painful motion associated with a muscle injury is consistent with fatigue-pain.  As noted in <a href=\"https://www.ecfr.gov/cgi-bin/text-idx?SID=8837da85076ce3ed1d7519c6c769a3bc&amp;mc=true&amp;node=se38.1.4_156&amp;rgn=div8\" target=\"_blank\">38 CFR 4.56(d)(2)(iii)</a>, a record of consistent complaint of one or more of the cardinal signs and symptoms of muscle disability is consistent with at least moderate disability of the muscles. </span></span></div></td></tr></tbody></table><div style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-family: arial , helvetica , sans-serif\"><span style=\"font-size: 14px\">V.iii.1.E.2.j<a id=\"2j\" name=\"2j\">.</a>  Applying the Amputation Rule to Muscle Injuries</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">The amputation rule applies to musculoskeletal conditions and any associated peripheral nerve injuries.  Therefore, when assigning separate evaluations for the muscle injury, peripheral nerve injury directly related to that muscle injury must be considered in applying the amputation rule.</span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\"><strong><em>References</em></strong>:  For more information on</span></span></div><ul><li><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">the amputation rule, see <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=3dcf139a08f4220f1b663624863f4c46&amp;node=se38.1.4_168&amp;rgn=div8\" target=\"_blank\">38 CFR 4.68</a>, and</span></span></li><li><div><span style=\"font-size: 14px\"><span style=\"font-family: arial , helvetica , sans-serif\">evaluating peripheral nerve disabilities associated with muscle injuries, see <a href=\"#2f\" target=\"_self\">M21-1, Part V, Subpart iii, 1.E.2.f</a>.</span></span></div></li></ul></td></tr></tbody></table><div style=\"margin-left: 85pt\"><hr/></div><table border=\"0\" cellpadding=\"0\" cellspacing=\"0\" style=\"border-spacing: 0px; border-collapse: revert;\"><tbody><tr><td style=\"width: 115px; vertical-align: top; padding: 0px;\"><h3><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">V.iii.1.E.2.k<a id=\"2k\" name=\"2k\">.</a>  Evaluating Muscle Disabilities Not Involving Shrapnel, GSWs, or Other Projectile-Type Injury</span></span></h3></td><td style=\"height: 8px; width: 15px; padding: 0px;\"></td><td style=\"width: 516px; vertical-align: top; padding: 0px;\"><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Generally, apply <a href=\"http://www.ecfr.gov/cgi-bin/text-idx?SID=3dcf139a08f4220f1b663624863f4c46&amp;node=se38.1.4_173&amp;rgn=div8\" target=\"_blank\">38 CFR 4.73</a> to muscle injuries such as those arising from shrapnel, GSWs, or other projectiles or similar foreign objects entering the muscle from outside the body since the criteria for the evaluation weigh heavily on the type of wound, treatment, and current manifestations of the wound. </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\"> </span></span></div><div><span style=\"font-size: 14px\"><span style=\"font-family: arial, helvetica, sans-serif\">Generally, a disability such as that arising from injuries such as muscle strains, tears not resulting from injury by a foreign object entering the muscle, or muscle atrophy due to a SC joint or nerve injury should be evaluated under an appropriate DC based on associated functional impairment.</span></span></div><div></div><div><span style=\"font-family: Arial, Helvetica, sans-serif\"><span style=\"font-size: 14px\"><em><strong>Exception</strong></em>:  Compartment syndrome is evaluated under <a href=\"https://www.ecfr.gov/current/title-38/chapter-I/part-4/subpart-B/subject-group-ECFRd3005f7d828ea7b/section-4.73\" target=\"_blank\">38 CFR 4.73, DC 5331</a> using the muscle injury evaluation criteria.</span></span></div></td></tr></tbody></table><div style=\"margin-left: 85pt\"><hr/></div></div><div class=\"ng-scope\" style=\"text-align: right\"><span style=\"font-size: 11px\"><span style=\"font-family: arial , helvetica , sans-serif\"><a articleid=\"554400000014418\" articlename=\"M21-1, Part V, Subpart iii, Chapter 1, Section D - Osteomyelitis\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014418/M21-1-Part-V-Subpart-iii-Chapter-1-Section-D-Osteomyelitis\">&lt;-- Previous Section</a>  <a articleid=\"554400000014425\" articlename=\"M21-1, Part V, Subpart iii, Chapter 1, Section F - Other Musculoskeletal Considerations\" articleviewcontext=\"article_view_related_article\" class=\"eGainArticleLink\" eg-link-click=\"\" href=\"/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014425/M21-1-Part-V-Subpart-iii-Chapter-1-Section-F-Other-Musculoskeletal-Considerations\">Next Section --&gt;</a></span></span></div><p class=\"ng-scope\" style=\"text-align: left\"><span style=\"font-family: arial , helvetica , sans-serif\"><a href=\"#top\" target=\"_self\"><span style=\"font-size: 11px\">To Top</span></a></span></p><p class=\"ng-scope\"></p></div>\n</div>",
  "external_links": [
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=016559808328edc689352a04140359bf&node=se38.1.4_155&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=016559808328edc689352a04140359bf&node=se38.1.4_173&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=174c60495ce1e9c0d4884c37335612a8&node=se38.1.4_173&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=3dcf139a08f4220f1b663624863f4c46&node=se38.1.4_168&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=3dcf139a08f4220f1b663624863f4c46&node=se38.1.4_173&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=58c48f445b6cd16d9747462b22ebb5f6&node=se38.1.4_156&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=70df8a154d2bdffaab9f94956057a637&node=se38.1.4_114&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=79ee3fbf439e8c4e6ee385ec809fbab9&node=se38.1.4_114&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=8fa6724d3188ec09c13ff6af41f7cf4c&node=se38.1.4_1118&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=9c0c584b7efb6e6d288e4bc92f6c1cca&mc=true&node=se38.1.4_155&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=cbc3aa622e44ec12918333696ffb3bff&node=se38.1.4_155&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=cbcf4a87e1bca06ca12cebf47eece30e&node=se38.1.4_156&rgn=div8http://www.ecfr.gov/cgi-bin/text-idx?SID=cbcf4a87e1bca06ca12cebf47eece30e&node=se38.1.4_156&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=cbcf4a87e1bca06ca12cebf47eece30e&node=se38.1.4_173&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=dfe9837fdb70e234eb6088450d0c7320&node=se38.1.4_155&rgn=div8",
    "http://www.ecfr.gov/cgi-bin/text-idx?SID=fac28fd48626614c9d2369ea61c7d14a&node=se38.1.4_197&rgn=div8",
    "https://www.ecfr.gov/cgi-bin/text-idx?SID=8837da85076ce3ed1d7519c6c769a3bc&mc=true&node=se38.1.4_156&rgn=div8",
    "https://www.ecfr.gov/current/title-38/chapter-I/part-4/subpart-B/subject-group-ECFRd3005f7d828ea7b/section-4.73"
  ],
  "scraped_at": "2025-06-16T22:43:43.780811",
  "next_section": "https://www.knowva.ebenefits.va.gov/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000014425/M21-1-Part-V-Subpart-iii-Chapter-1-Section-F-Other-Musculoskeletal-Considerations"
}